Literature DB >> 28386643

[Obesity and autoimmunity : Adipose tissue as an immune organ?]

S Thrum1.   

Abstract

Adipose tissue possesses crucial immunological features in the development of comorbidities of obesity. Complex interactions between the metabolic system and cells of the immune system are the cause but are not fully understood. Autoimmune diseases might therefore be influenced by obesity. Epidemiological studies provide evidence of only a modest association between obesity and the development of rheumatoid arthritis and psoriatic arthritis. In obesity the course of inflammatory rheumatic diseases is aggravated, as subjectively measured by activity parameters; however, laboratory parameters show no differences and radiographic examinations reveal less bone destruction in obesity. Furthermore, there are indications for a poorer response to treatment especially with infliximab in patients with an increased body mass index (BMI). Weight loss has a positive effect on the course of joint diseases. Due to deficits in the currently available studies there is insufficient evidence to recommend individualization of treatment decisions based on the BMI.

Entities:  

Keywords:  Autoimmune diseases; Body mass index; Immune system; Metabolic system; Weight reduction

Mesh:

Year:  2017        PMID: 28386643     DOI: 10.1007/s00393-017-0298-0

Source DB:  PubMed          Journal:  Z Rheumatol        ISSN: 0340-1855            Impact factor:   1.372


  9 in total

Review 1.  Systemic and Local Adipose Tissue in Knee Osteoarthritis.

Authors:  Elisa Belluzzi; Hamza El Hadi; Marnie Granzotto; Marco Rossato; Roberta Ramonda; Veronica Macchi; Raffaele De Caro; Roberto Vettor; Marta Favero
Journal:  J Cell Physiol       Date:  2017-03-03       Impact factor: 6.384

2.  Immunological complications of obesity.

Authors:  Thirumala-Devi Kanneganti; Vishwa Deep Dixit
Journal:  Nat Immunol       Date:  2012-07-19       Impact factor: 25.606

3.  Body mass does not impact the clinical response to intravenous abatacept in patients with rheumatoid arthritis. Analysis from the "pan-European registry collaboration for abatacept (PANABA).

Authors:  Florenzo Iannone; Delphine S Courvoisier; Jacques Eric Gottenberg; Maria Victoria Hernandez; Elisabeth Lie; Helena Canhão; Karel Pavelka; Merete Lund Hetland; Carl Turesson; Xavier Mariette; Denis Choquette; Axel Finckh
Journal:  Clin Rheumatol       Date:  2016-12-14       Impact factor: 2.980

Review 4.  The Obesity Epidemic and Consequences for Rheumatoid Arthritis Care.

Authors:  Michael D George; Joshua F Baker
Journal:  Curr Rheumatol Rep       Date:  2016-01       Impact factor: 4.592

Review 5.  Impact of obesity on the clinical outcome of rheumatologic patients in biotherapy.

Authors:  Florenzo Iannone; Giuseppe Lopalco; Donato Rigante; Ida Orlando; Luca Cantarini; Giovanni Lapadula
Journal:  Autoimmun Rev       Date:  2016-01-22       Impact factor: 9.754

Review 6.  Interplay between the immune system and adipose tissue in obesity.

Authors:  Mark A Exley; Laura Hand; Donal O'Shea; Lydia Lynch
Journal:  J Endocrinol       Date:  2014-09-16       Impact factor: 4.286

Review 7.  Obesity and inflammatory arthritis: impact on occurrence, disease characteristics and therapeutic response.

Authors:  Claire I Daïen; Jérémie Sellam
Journal:  RMD Open       Date:  2015-06-29

8.  Body mass index distribution in rheumatoid arthritis: a collaborative analysis from three large German rheumatoid arthritis databases.

Authors:  Katinka Albrecht; Adrian Richter; Johanna Callhoff; Dörte Huscher; Georg Schett; Anja Strangfeld; Angela Zink
Journal:  Arthritis Res Ther       Date:  2016-06-23       Impact factor: 5.156

Review 9.  Impact of body weight on the achievement of minimal disease activity in patients with rheumatic diseases: a systematic review and meta-analysis.

Authors:  Roberta Lupoli; Paolo Pizzicato; Antonella Scalera; Pasquale Ambrosino; Manuela Amato; Rosario Peluso; Matteo Nicola Dario Di Minno
Journal:  Arthritis Res Ther       Date:  2016-12-13       Impact factor: 5.156

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.